References
- 1. Brignole M, Auricchio A, Baron-Esquivias G, et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J. 2013;34:2281-2329. doi:10.1093/eurheartj/eht150.10.1093/eurheartj/eht150
- 2. Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18:891-975. doi:10.1002/ejhf.592.10.1002/ejhf.592
- 3. Bui AL, Horwich TB, Fonarow GC. Epidemiology and risk profile of heart failure. Nat Rev Cardiol. 2011;8:30-41. doi: 10.1038/nrcardio.2010.165.10.1038/nrcardio.2010.165
- 4. Arsenescu Georgescu C, Gaitan A, Stătescu C. On Cardiac Resynchronization Therapy. Romanian Journal of Artistic Creativity. 2014;2:7-13.
- 5. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med. 2005;352:1539-1549. doi: 10.1056/NEJMoa050496.10.1056/NEJMoa050496
- 6. Rinkuniene D, Bucynte S, Abrasmavicius S, et al. Predictors of positive response to cardiac resynchronization therapy. BMC Cardiovascular Disorders. 2014;14:55. doi: 10.1186/1471-2261-14-55.10.1186/1471-2261-14-55
- 7. Thibault B, Harel F, Ducharme A, et al. Cardiac resynchronization therapy in patients with heart failure and a QRS complex <120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSEREARTH) trial. Circulation. 2013;127:873-881. doi: 10.1161/CIRCULATIONAHA.112.001239.10.1161/CIRCULATIONAHA.112.001239
- 8. Sipahi I, Carrigan TP, Rowland DY, Stambler BS, Fang JC. Impact of QRS duration on clinical event reduction with cardiac resynchronization therapy: meta-analysis of randomized controlled trials. Arch Intern Med. 2011;171:1454-1462. doi: 10.1001/archinternmed.2011.247.
- 9. Cheng A, Landman SR, Stadler RW. Reasons for loss of cardiac resynchronization therapy pacing insights from 32844 patients. Circulation: Arrhythmia and Electrophysiology. 2012;5:884-888. doi: 10.1161/CIRCEP.112.973776
- 10. Florea M, Arsenescu Georgescu C. Atrial Fibrilation from Phisyopathology to Ablation. Iași: Editura Grigore T. Popa University of Medicine, 2013; p. 264-305.
- 11. Santangeli P, Di Biase L, Pelargonio G, et al. Cardiac resynchronization therapy in patients with mild heart failure: a systematic review and meta-analysis. J Interv Card Electrophysiol. 2011;32:125-135. doi: 10.1007/s10840-011-9584-y.10.1007/s10840-011-9584-y
- 12. Arsenescu Georgescu C, Stătescu C, Macovei L. Interventional Cardiology in elderly. In: News in geriatrics. Iași: Editura Grigore T. Popa University of Medicine, 2011; p. 125-136.
- 13. Linde C, Leclercq C, Rex S, et al. Long-term benefits of biventricular pacing in congestive heart failure: results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study. J Am Coll Cardiol. 2002;40:111-118.10.1016/S0735-1097(02)01932-0
- 14. Pires LA, Abraham WT, Young JB, et al. Clinical predictors and timing of New York Heart Association class improvement with cardiac resynchronization therapy in patients with advanced chronic heart failure: results from the Multicenter InSync Randomized Clinical Evaluation (MIRACLE) and Multicenter InSync ICD Randomized Clinical Evaluation (MIRACLEICD) trials. Am Heart J. 2006;151:837-843. doi: 10.1016/j.ahj.2005.06.024.10.1016/j.ahj.2005.06.024
- 15. Anand IS, Carson P, Galle E, et al. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: results from the Comparison of Medical Therapy, Pacing and Defibrillation in Heart Failure (COMPANION) trial. Circulation. 2009;119:969-977. doi: 10.1161/CIRCULATIONAHA.108.793273.10.1161/CIRCULATIONAHA.108.793273
- 16. Cleland JGF, Daubert JC, Erdmann E, et al. The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure. N Engl J Med. 2005;352:1539-1549. doi: 10.1056/NEJMoa050496.10.1056/NEJMoa050496
- 17. Stătescu C, Arsenescu Georgescu C. The prognosis of patients with cardiac pacemaker by pacing site. In: News in geriatrics. Iași: Editura Grigore T. Popa University of Medicine, 2011; p. 143-152.
- 18. Sawhney NS, Waggoner AD, Garhwal S, Chawla MK, Osborn J, Faddis MN. Randomized prospective trial of atrioventricular delay programming for cardiac resynchronization therapy. Heart Rhythm. 2004;1:562-567. doi: 10.1016/j.hrthm.2004.07.006.10.1016/j.hrthm.2004.07.006
- 19. Luderitz B. We have come a long way with device therapy: historical perspective on antiarythmic electrotherapy. J Cardiovasc Electrophysiol. 2002;13(1 Suppl):S2-8.
- 20. Garcia Seara J, Martinez-Saude JL, Cid B, et al. Influence of the Preimplantation QRS Axis on Responses to Cardiac Resynchronization Therapy. Rev Esp. Cardiol. 2008;61:1245-1255. doi: 10.1016/S1885-5857(09)60051-7.10.1016/S1885-5857(09)60051-7
- 21. Teh AW, Medi C, Rosso R, Lee G, Gurvitch R, Mond HG. Pacing from the right septum is there a danger to the coronary arteries? Pacing Clin Electrophysiol. 2009;32:894-897. doi: 10.1111/j.1540-8159.2009.02405.x.10.1111/j.1540-8159.2009.02405.x
- 22. Thibault B, Ducharme A, Harel F, et al. Left ventricular versus simultaneous biventricular pacing in patients with heart failure and a QRS complex >120ms. Circulation. 2011;124:2874-2881. doi: 10.1161/CIRCULATIONAHA.111.032904.10.1161/CIRCULATIONAHA.111.032904
- 23. Stătescu C, Arsenescu Georgescu C. Pacing Site – From Theory to Practice. In: Kibos AS et al., Cardiac Arrhythmias. London: Springer, 2014; p. 605-609.